CCO: Commentary, Hepatitis Update, EACS

CCO UPDATE 

   We are pleased to announce more unique content for HIV healthcare
   providers, now available on the Clinical Care Options for HIV Web site
   at http://clinicaloptions.com/hiv

   Next week we will be covering the 9th European AIDS Conference in
   Warsaw, Poland. Check back during the week for news reports and
   Capsule Summaries of all the most important data, followed by debate
   and analysis of the clinical implications from leading international
   authorities.

   We are also delighted to announce the launch of the new Clinical Care
   Options for Hepatitis Web site at http://clinicaloptions.com/hep

   Visit it today to access the Hepatitis Annual Update 2003, a
   comprehensive collection of state-of-the-art review articles,
   including modules on HBV treatment, HCV treatment, new agents, and
   HIV/HCV coinfection. And next week, check back for coverage of the
   43rd AASLD meeting, again including a track on HIV/HCV coinfection.

   Finally, don't miss our latest Expert Viewpoint in which Stephen L.
   Becker, MD, discusses the most recent DHHS guidelines and reviews the
   most significant new recommendations, as well as some notable
   omissions.

   Edward King
   Editorial Director
   [EMAIL PROTECTED]
   _________________

   Editorial suggestions or comments? Email [EMAIL PROTECTED]
   Technical problems with the site? Email [EMAIL PROTECTED]
   _________________

   COMMENTARY

   New DHHS Guidelines: What's New, and What's Missing
     http://clinicaloptions.com/go/hivevoct03

   "The new edition of the guidelines is extensive in its review of the
   multiple considerations in the treatment of HIV disease, and differs
   in several ways from recommendations issued previously."

   In our latest Expert Viewpoint, Stephen L. Becker, MD reviews the
   changes and omissions in the latest treatment guidelines.

   ONLINE CME PROGRAMS

   Hepatitis Annual Update 2003
     http://clinicaloptions.com/go/hepupdate2003

   The management of hepatitis coinfection in HIV-infected patients
   represents a major challenge for clinicians. In this state-of-the-art
   resource, 11 world-class authorities review the past year's
   developments in hepatitis medicine, including:

     * HCV/HIV Coinfection: Raymond T. Chung, MD

     * State-of-the-Art Treatment of Hepatitis B: Teresa L. Wright, MD

     * State-of-the-Art Treatment of Hepatitis C: Gary L. Davis, MD

     * Managing Psychiatric Side Effects of Interferon: Charles L.
       Raison, MD

     * Managing the Hematologic Complications of Interferon/Ribavirin:
       Mark S. Sulkowski, MD

     * Novel Therapies in HBV and HCV: John G. McHutchison, MD

   CONFERENCE COVERAGE

   9th European AIDS Conference
   October 25-29, 2003; Warsaw, Poland
     http://clinicaloptions.com/eacs

   Coming soon! A unique program combining easy-to-use data summaries
   with expert analysis:

     * Daily news stories covering the latest breaking news

     * Capsule Summaries of each of the important studies

     * Expert Analyses of the key data on each topic by panels of
       world-renowned experts

   Organized by tracks:

     * Antiretroviral Therapy: Efficacy, Resistance, & Pharmacology

     * Complications: Adverse Effects, Coinfections, and OIs

   World-renowned faculty:
     * David A. Cooper, MD, DSc
     * Peter Reiss, MD, PhD
     * Professor Dr. med. Jurgen Rockstroh
     * Vincent Soriano, MD
     * Mike Youle, MB, ChB
     * Benjamin Young, MD, PhD

   OTHER RECENTLY PUBLISHED PROGRAMS

   Cardiovascular Risk Factors & Metabolic Complications In Patients
   Receiving HAART
     http://clinicaloptions.com/go/cardio

   New Agents & Strategies For Treatment-Experienced HIV Patients
     http://clinicaloptions.com/go/newagents

   Antiretroviral Drug Resistance & Sequencing: Mechanisms, Measurements
   And Management
     http://clinicaloptions.com/go/resistance

   Coverage of the 43rd Annual ICAAC Meeting
     http://clinicaloptions.com/go/icaac2003

   Coverage of the 2nd IAS Conference on HIV Pathogenesis and Treatment
     http://clinicaloptions.com/go/ias2003

   Coverage of the 10th Conference on Retroviruses and Opportunistic
   Infections
     http://clinicaloptions.com/go/croi2003

   RECENT NEWS REPORTS
     http://clinicaloptions.com/go/hivnews

     * New form of liposuction able to reduce buffalo hump, at least in
       the short term

     * Australian therapeutic vaccine shows promise in treatment
       interruption

     * HAART continues to improve survival, but not all HIV risk groups
       benefit equally

     * Don't use tenofovir DF/didanosine/lamivudine combination, warns
       Gilead

     * Less than 40% of HIV-positive Swiss cohort have CD4+ cell count
       above 500 after 4 years of HAART

     * Zidovudine and nevirapine after birth reduce HIV transmission

     * Switching from a PI? NEFA study shows risks and benefits of
       abacavir

     * Nevirapine causes acute hepatitis in 2.6% of HIV-positive
       recipients in case series

   All Clinical Care Options for HIV content is free to use and available
   to everyone after a quick, one-time registration process.

   If you do not wish to receive future announcements about Clinical Care
   Options for HIV programs, send an email to [EMAIL PROTECTED]